TELA Bio Inc [TELA] stock is trading at $4.63, up 2.77%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The TELA shares have gain 4.04% over the last week, with a monthly amount drifted -12.64%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
TELA Bio Inc [NASDAQ: TELA] stock has seen the most recent analyst activity on May 31, 2022, when Lake Street initiated its Buy rating and assigned the stock a price target of $17. On December 03, 2019, JMP Securities initiated with a Mkt Outperform rating. Jefferies started tracking the stock assigning a Buy rating. Canaccord Genuity initiated its recommendation with a Buy.
TELA Bio Inc [TELA] stock has fluctuated between $4.23 and $11.26 over the past year. Currently, Wall Street analysts expect the stock to reach $17.5 within the next 12 months. TELA Bio Inc [NASDAQ: TELA] shares were valued at $4.63 at the most recent close of the market. An investor can expect a potential return of 277.97% based on the average TELA price forecast.
Analyzing the TELA fundamentals
TELA Bio Inc [NASDAQ:TELA] reported sales of 58.45M for the trailing twelve months, which represents a growth of 46.26%. Gross Profit Margin for this corporation currently stands at 0.69% with Operating Profit Margin at -0.75%, Pretax Profit Margin comes in at -0.8%, and Net Profit Margin reading is -0.83%. To continue investigating profitability, this company’s Return on Assets is posted at -0.62, Equity is -2.1 and Total Capital is -0.72. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of2.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.51 points at the first support level, and at 4.38 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.75, and for the 2nd resistance point, it is at 4.86.
TELA Bio Inc [TELA] reported earnings per share of -$0.53 for its fiscal quarter that ended on 12/31/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.43/share, meaning a difference of -$0.1 and a surprise factor of -23.30%. By comparison, the stated earnings for the previous quarter ended on 9/30/2023 were -$0.45 per share as compared to estimates of -$0.49 per share, a difference of $0.04 representing a surprise of 8.20%.
Ratios To Look Out For
For context, TELA Bio Inc’s Current Ratio is 4.23. Further, the Quick Ratio stands at 3.45, while the Cash Ratio is 2.75. Considering the valuation of this stock, the price to sales ratio is 1.95, the price to book ratio is 6.01.
Transactions by insiders
Recent insider trading involved Firestone Gregory A., Chief Business Officer, that happened on Dec 05 ’23 when 2600.0 shares were purchased. Chief Executive Officer, KOBLISH ANTONY completed a deal on Nov 14 ’23 to buy 11000.0 shares. Meanwhile, COO and CFO Cuca Roberto bought 10000.0 shares on Nov 14 ’23.
